Reviewing peer review

Peer review is on every life scientist?s mind lately, it seems. One of the main complaints I heard while researching the linkurl:February cover story;http://www.the-scientist.com/2006/2/1/26/1/ is that the process is inherently difficult to investigate scientifically. Each journal has a somewhat unique system for reviewing papers, and each paper will have a unique journey through a journal?s reviewing machinery. But I?ve learned that even though peer review has obvious imperfections, it?s the b

Written byAlison McCook
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
Peer review is on every life scientist?s mind lately, it seems. One of the main complaints I heard while researching the linkurl:February cover story;http://www.the-scientist.com/2006/2/1/26/1/ is that the process is inherently difficult to investigate scientifically. Each journal has a somewhat unique system for reviewing papers, and each paper will have a unique journey through a journal?s reviewing machinery. But I?ve learned that even though peer review has obvious imperfections, it?s the best system we?ve got, and simply complaining about what?s wrong with it doesn?t help matters much. Investigating peer review is difficult, sure, but does that mean we shouldn?t even try? Kirby Lee, an assistant professor of clinical pharmacy, and his colleagues at the University of California, San Francisco, have spent a year and a half collecting data about the peer review process at The Lancet, Annals of Internal Medicine, and BMJ. The data, also reported in Nature, stem from interviews with editors, peer review comments from more than 1,000 papers, and audio and video recordings of editorial meetings where editors discussed the papers. Lee told me that his team planned on spending six months collecting data, but had to significantly extend the enrollment period "because the acceptance rate was so low." In fact, out of all the papers included in the study, the journals published only 68. Some other interesting findings: -There appeared to be no bias towards statistically significant findings, although Lee cautioned that the same trend may not be true at other journals, or at the same journals during a different time period. -Major changes editors tend to make between acceptance and final publication include toning down authors? conclusions, and ensuring that the manuscripts disclose funding sources and conflicts of interest. -The methodological quality is higher in accepted papers than rejected ones. Lee said that the study was originally going to include JAMA, but the journal dropped out without providing a clear reason why. He and his colleagues decided to conduct the study to investigate complaints of publication bias, which can skew the research record and affect meta-analyses. They focused on biomedical publishing because what?s published can lead to changes in the way medicine is practiced. In the meantime, Lee and his colleagues continue to analyze the hours of tapes collected from editorial meetings, and have already submitted one paper describing their research, currently under review. "It?s funny," he said. "We?ve done this study on peer review, and now we?re at the mercy of peer reviewers."
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo
Explore new strategies for improving plasmid DNA manufacturing workflows.

Overcoming Obstacles in Plasmid DNA Manufacturing

cytiva logo

Products

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery

brandtechscientific-logo

BRANDTECH Scientific Launches New Website for VACUU·LAN® Lab Vacuum Systems